Toripalimab

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Name
Toripalimab
Accession Number
DB15043
Type
Biotech
Groups
Investigational
Description

Toripalimab is under investigation in clinical trial NCT03919383 (Phase II of Lenvatinib Plus Toripalimab for Advanced HCC).

Synonyms
Not Available
Categories
Not Available
UNII
8JXN261VVA
CAS number
1924598-82-2

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
Not Available
Food Interactions
Not Available

References

General References
Not Available
External Links
Not Available

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
1Active Not RecruitingTreatmentLung Cancer Non-Small Cell Cancer (NSCLC)1
1Active Not RecruitingTreatmentLung Cancers / Malignant Lymphomas1
1Active Not RecruitingTreatmentMalignant Lymphomas1
1RecruitingTreatmentMalignant Neoplasm of Colon / MSI-H1
1, 2Active Not RecruitingTreatmentGastric Adenocarcinoma / Head and Neck Squamous Cell Carcinoma (HNSCC) / Nasopharyngeal Carcinoma / Squamous Cell Carcinoma of Esophagus1
1, 2Not Yet RecruitingTreatmentChemotherapy Effect / Colonic Neoplasms1
1, 2Not Yet RecruitingTreatmentEpatocellular Carcinoma, Intrahepatic Cholangiocarcinoma1
2Active Not RecruitingTreatmentEfficacy and Safety1
2Not Yet RecruitingTreatmentAdvanced Cholangiocarcinoma1
2Not Yet RecruitingTreatmentLung Cancer Small Cell Lung Cancer (SCLC)1
2Not Yet RecruitingTreatmentSoft Tissue Sarcoma (STS) / Undifferentiated Pleomorphic Sarcoma1
2RecruitingTreatmentBiliary Tract Cancer1
2RecruitingTreatmentCancer, Advanced / Small Cell Carcinoma of Esophagus1
2RecruitingTreatmentCancer, Advanced / Tumors, Solid1
2RecruitingTreatmentEsophageal Squamous Cell Carcinoma by AJCC V8 Stage / Resectable Esophageal Cancer1
2RecruitingTreatmentUnresectable Esophageal Cancer1
2WithdrawnTreatmentHepatocellular,Carcinoma1
2, 3Not Yet RecruitingTreatmentHepatocellular,Carcinoma1
2, 3RecruitingTreatmentNeuroendocrine Carcinoma of the Bladder1
3Not Yet RecruitingTreatmentLung Cancer Non-Small Cell Cancer (NSCLC)1
3RecruitingTreatmentAdvanced Melanoma1
3RecruitingTreatmentAdvanced or Metastatic Esophageal Squamous Cell Cancer Without Previous Systemic Chemotherapy1
3RecruitingTreatmentHead/Neck Neoplasm1
3RecruitingTreatmentLiver Cancer1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Taxonomy

Classification
Not classified

Drug created on May 20, 2019 08:44 / Updated on May 21, 2019 12:34